A0520 – Efficacy and safety of cabazitaxel for ≥80 years of elderly patients with metastatic castration resistant prostate cancer
Authors:
- K. SuzukiKSK. Suzuki
- H. UekiHUH. Ueki
- N. WakitaNWN. Wakita
- Y. OkamuraYOY. Okamura
- Y. BandoYBY. Bando
- T. HaraTHT. Hara
- T. TerakawaTTT. Terakawa
- K. ChibaKCK. Chiba
- J. TeishimaJTJ. Teishima
- H. MiyakeHMH. Miyake
- 25 September 2025
- journal article
- Published by Elsevier in European Urology
- Vol. 87, S1341